Merck (MRK) Announces Submission of KEYTRUDA sBLA to U.S. FDA
Tweet Send to a Friend
Merck (NYSE: MRK) announced that the company has submitted a supplemental Biologics License Application to the U.S. Food and Drug ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE